Article Details

Boston Scientific Farapulse trial highlights post-ablation arrhythmia burden's effect on outcomes

Retrieved on: 2024-05-18 18:10:28

Tags for this article:

Click the tags to see associated articles and topics

Boston Scientific Farapulse trial highlights post-ablation arrhythmia burden's effect on outcomes. View article details on hiswai:

Excerpt

MEDTECH 100 Stock INDEX. Medtech 100 logo. Market Summary > Current Price. $82.08. May 17, 2024 at 1:00 PM PDT. The MedTech 100 is a financial index ...

Article found on: www.massdevice.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up